Browsing by Author Ohlschlegel, Christian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2008Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study GroupCoates, Alan; Braye, Stephen; Brown, Robert; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Gusterson, Barry A.; Kovacs, Aniko; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Perin, Tiziana; Pillay, Komala; Price, Karen N.; Regan, Meredith M.; Rusca, Tiziana; Viale, Giuseppe; School of Public Health: Public HealthChemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study Group, Journal of Clinical Oncology, vol.26, 9, 2008,pp 1404-1410
2012Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsCoates, Alan; Gelber, Richard D. (Prof); Gelber, S.; Goldhirsch, Aron; Huober, J; Ohlschlegel, Christian; Price, K. N; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthPrognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials, Annals of Oncology, vol.23, 11, 2012,pp 2843-2851
2008Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With LetrozoleCoates, Alan; Braye, Stephen; Dell'Orto, Patrizia; et al, Various; Giobbie-Hurder, Anita; MacGrogan, Gaetan; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPrognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole, Journal of Clinical Oncology, vol.26, 34, 2008,pp 5569-5575